Health and Healthcare

Wednesday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

BIONOVO INC [BNVI.OB] +27.33% $0
CORCEPT THERAPEUTICS [CORT] +20.19% $99.2 M
OPEXA THERAPEUTICS [OPXA] +11.11% $0
PANACOS PHARMA INC [PANC] +8.29% $49.9 M
AURIGA LABORATORIES [ARGA.OB] +7.14%

Diagnostic Substances

ICAGEN, INC. [ICGN] +20.93%
AVALON PHARMACEUTIC [AVRX] +6.71%
THRESHOLD PHARMACEUT [THLD] +4.64%
NYMOX PHARM CORP [NYMX] +4.17%
SCOLR PHARMA INC [DDD] +3.31%

Drug Delivery

SYMBOLLON PHARM CL A [SYMBA.OB] +7.14%
DELCATH SYSTEMS INC [DCTH] +1.96%
EMISPHERE TECH [EMIS] +0.95%
ALKERMES INC [ALKS] +0.91%
QUIGLEY CORP THE [QGLY] +0.90%

Drug Manufacturers

GENTIUM SPA ADS [GENT] +4.37%
EXEGENICS INC [EXEG.OB] +4.32%
SINOVAC BIOTECH LTD [SVA] +4.32%
PROVECTUS PHARMA [PVCT.OB] +3.57% $11.0 M
SPECTRUM PHARMA INC [SPPI] +2.91%

Medical Appliances & Equipment

BSD MEDICAL CORP [BSM] +14.96%
THERAGENICS CORP [TGX] +9.91%
MEDICALCV INC [MCVI.OB] +7.39%
CELSION CORP [CLN] +6.60%
SYNERGETICS USA INC [SURG] +4.96%

Medical Instruments & Supplies

ELECTRO-OPTICAL SCIE [MELA] +13.55%
BIOFORCE NANOSCIENCE [BFNH.OB] +13.24%
HEMOSENSE INC. [HEM] +7.34%
BIOJECT MEDICAL [BJCT] +6.09%
NUVASIVE, INC. [NUVA] +5.76%

http://www.biohealthinvestor.com/

Medical Laboratories & Research

ERESEARCHTECHNOLOG [ERES] +2.14%
BIO-IMAGING TECH [BITI] +1.84%
ALLIANCE IMAGING INC [AIQ] +1.82%
RADNET INC [RDNT] +1.41%
GENOMIC HEALTH, INC. [GHDX] +0.97%

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.